COMMUNIQUÉS West-GlobeNewswire
-
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
27/08/2024 - 18:53 -
Priority Health, Curai Health partner to offer free virtual health visits to Michigan’s uninsured population
27/08/2024 - 19:17 -
Oculis Publishes Consolidated Q2 Financial Statements and MD&A
27/08/2024 - 22:00 -
LENZ Therapeutics to Participate in Upcoming Investor Conferences
27/08/2024 - 22:01 -
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
27/08/2024 - 22:05 -
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
27/08/2024 - 22:05 -
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
27/08/2024 - 22:05 -
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
27/08/2024 - 22:05 -
Fulcrum Therapeutics to Participate in Upcoming September Conferences
27/08/2024 - 22:05 -
Health Catalyst to Participate in Upcoming Investor Conferences
27/08/2024 - 22:05 -
Psyence Biomed to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
27/08/2024 - 22:05 -
Cingulate to Participate in Benzinga All Live Access Event
27/08/2024 - 22:30 -
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
27/08/2024 - 22:30 -
MannKind to Present at Upcoming Conferences
27/08/2024 - 22:30 -
LeMaitre to Participate at Upcoming Investor Conferences in September
27/08/2024 - 22:54 -
EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community
26/08/2024 - 15:00 -
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amyotrophic Lateral Sclerosis (ALS)
26/08/2024 - 15:00 -
Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
26/08/2024 - 15:00 -
Positron Corporation Announces Sale of NeuSight PET-CT Scanner
26/08/2024 - 15:00
Pages